What is the number of injections for de Quervain's tenosynovitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For De Quervain's tenosynovitis, typically 1-2 corticosteroid injections are recommended, as supported by the American College of Radiology's appropriateness criteria 1. When considering the treatment of De Quervain's tenosynovitis, it is essential to prioritize the number of injections to balance efficacy and potential side effects.

  • The first injection usually resolves symptoms in about 50-80% of patients.
  • A second injection may be offered if symptoms persist after 4-6 weeks. The injection typically consists of a mixture of a corticosteroid (such as methylprednisolone 20-40mg or triamcinolone 10-20mg) combined with a local anesthetic (like lidocaine 1%), and is injected into the first dorsal compartment of the wrist where the abductor pollicis longus and extensor pollicis brevis tendons are located, as identified by ultrasound (US) examination 1. Key considerations for the treatment include:
  • Multiple injections (more than 2-3) are generally not recommended due to potential side effects including skin atrophy, depigmentation, and tendon weakening.
  • If symptoms persist after two injections, surgical release of the tendon sheath may be considered. The use of US to guide therapeutic intra-articular and other soft-tissue injections, such as those for De Quervain's tenosynovitis, is a useful technique, as noted in the American College of Radiology's guidelines 1.

From the Research

De Quervain's Tenosynovitis Treatment

  • De Quervain's tenosynovitis is a disorder characterized by pain on the radial side of the wrist and functional disability of the hand 2.
  • The treatment options for de Quervain's tenosynovitis include corticosteroid injection, splinting, and surgery.

Corticosteroid Injection

  • Corticosteroid injections are a common treatment for de Quervain's tenosynovitis, with a high success rate 3, 4, 5.
  • The efficacy of corticosteroid injections for de Quervain's tenosynovitis has been studied in several trials, with one trial finding that 73.4% of patients experienced treatment success within 2 injections 3.
  • Another study found that 82% of patients had resolved symptoms 6 weeks after a steroid injection, and over half remained symptom-free for at least 12 months 4.
  • A pooled quantitative literature evaluation found an 83% cure rate with injection alone, which was higher than any other therapeutic modality 5.

Number of Injections

  • The number of injections needed to treat de Quervain's tenosynovitis can vary, with some studies suggesting that one or two injections are sufficient 3, 4.
  • One study found that 51.8% of patients experienced success after 1 injection, while 73.4% experienced treatment success within 2 injections 3.
  • Another study found that 11 patients underwent additional intervention, including 4 repeat injections, after an initial injection 4.

Predictors of Treatment Outcome

  • Several studies have identified predictors of treatment outcome, including body mass index (BMI) and female sex 3.
  • One study found that BMI >30 and female sex were significantly associated with treatment failure, with a 2.4-fold increase and 3.23 times greater odds of failure, respectively 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.